Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma.
Kang CW, Jang KW, Sohn J, Kim SM, Pyo KH, Kim H, Yun MR, Kang HN, Kim HR, Lim SM, Moon YW, Paik S, Kim DJ, Kim JH, Cho BC.
Kang CW, et al. Among authors: lim sm.
Mol Cancer Ther. 2015 Oct;14(10):2238-48. doi: 10.1158/1535-7163.MCT-15-0350. Epub 2015 Jul 24.
Mol Cancer Ther. 2015.
PMID: 26208525